Table of Contents United States Biodefense Market Report 2018 1 Biodefense Overview 1.1 Product Overview and Scope of Biodefense 1.2 Classification of Biodefense by Product Category 1.2.1 United States Biodefense Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States Biodefense Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 Anthrax 1.2.4 Smallpox 1.2.5 Botulism 1.2.6 Radiation/Nuclear 1.2.7 Others 1.3 United States Biodefense Market by Application/End Users 1.3.1 United States Biodefense Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 US Military Market 1.3.3 US Civilian Market 1.3.4 Non - US Market 1.4 United States Biodefense Market by Region 1.4.1 United States Biodefense Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West Biodefense Status and Prospect (2013-2025) 1.4.3 Southwest Biodefense Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic Biodefense Status and Prospect (2013-2025) 1.4.5 New England Biodefense Status and Prospect (2013-2025) 1.4.6 The South Biodefense Status and Prospect (2013-2025) 1.4.7 The Midwest Biodefense Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of Biodefense (2013-2025) 1.5.1 United States Biodefense Sales and Growth Rate (2013-2025) 1.5.2 United States Biodefense Revenue and Growth Rate (2013-2025) 2 United States Biodefense Market Competition by Players/Suppliers 2.1 United States Biodefense Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States Biodefense Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States Biodefense Average Price by Players/Suppliers (2013-2018) 2.4 United States Biodefense Market Competitive Situation and Trends 2.4.1 United States Biodefense Market Concentration Rate 2.4.2 United States Biodefense Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Biodefense Manufacturing Base Distribution, Sales Area, Product Type 3 United States Biodefense Sales (Volume) and Revenue (Value) by Region (2013-2018) 3.1 United States Biodefense Sales and Market Share by Region (2013-2018) 3.2 United States Biodefense Revenue and Market Share by Region (2013-2018) 3.3 United States Biodefense Price by Region (2013-2018) 4 United States Biodefense Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018) 4.1 United States Biodefense Sales and Market Share by Type (Product Category) (2013-2018) 4.2 United States Biodefense Revenue and Market Share by Type (2013-2018) 4.3 United States Biodefense Price by Type (2013-2018) 4.4 United States Biodefense Sales Growth Rate by Type (2013-2018) 5 United States Biodefense Sales (Volume) by Application (2013-2018) 5.1 United States Biodefense Sales and Market Share by Application (2013-2018) 5.2 United States Biodefense Sales Growth Rate by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 United States Biodefense Players/Suppliers Profiles and Sales Data 6.1 Emergent Biosolutions 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Biodefense Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Emergent Biosolutions Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Hytest 6.2.2 Biodefense Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Hytest Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 GSK 6.3.2 Biodefense Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 GSK Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Sanofi 6.4.2 Biodefense Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Sanofi Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 PharmAthene 6.5.2 Biodefense Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 PharmAthene Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Bavarian Nordic 6.6.2 Biodefense Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Bavarian Nordic Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 SIGA Technologies 6.7.2 Biodefense Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 SIGA Technologies Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 Arbutus Biopharma 6.8.2 Biodefense Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Arbutus Biopharma Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 DynPort Vaccine 6.9.2 Biodefense Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 DynPort Vaccine Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Xoma Corporation 6.10.2 Biodefense Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Xoma Corporation Biodefense Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 Ichor Medical Systems 6.12 Aeolus Pharmaceuticals 6.13 Achaogen 6.14 Elusys Therapeutics 6.15 Dynavax Technologies 6.16 Cleveland BioLabs 6.17 Soligenix 6.18 Alnylam Pharmaceuticals 7 Biodefense Manufacturing Cost Analysis 7.1 Biodefense Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Biodefense 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Biodefense Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Biodefense Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Biodefense Market Size (Value and Volume) Forecast (2018-2025) 11.1 United States Biodefense Sales Volume, Revenue Forecast (2018-2025) 11.2 United States Biodefense Sales Volume Forecast by Type (2018-2025) 11.3 United States Biodefense Sales Volume Forecast by Application (2018-2025) 11.4 United States Biodefense Sales Volume Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Biodefense Figure United States Biodefense Market Size (K Units) by Type (2013-2025) Figure United States Biodefense Sales Volume Market Share by Type (Product Category) in 2017 Figure Anthrax Product Picture Figure Smallpox Product Picture Figure Botulism Product Picture Figure Radiation/Nuclear Product Picture Figure Others Product Picture Figure United States Biodefense Market Size (K Units) by Application (2013-2025) Figure United States Sales Market Share of Biodefense by Application in 2017 Figure US Military Market Examples Table Key Downstream Customer in US Military Market Figure US Civilian Market Examples Table Key Downstream Customer in US Civilian Market Figure Non - US Market Examples Table Key Downstream Customer in Non - US Market Figure United States Biodefense Market Size (Million USD) by Region (2013-2025) Figure The West Biodefense Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest Biodefense Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic Biodefense Revenue (Million USD) and Growth Rate (2013-2025) Figure New England Biodefense Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US Biodefense Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest Biodefense Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Biodefense Sales (K Units) and Growth Rate (2013-2025) Figure United States Biodefense Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Biodefense Market Major Players Product Sales Volume (K Units) (2013-2018) Table United States Biodefense Sales (K Units) of Key Players/Suppliers (2013-2018) Table United States Biodefense Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States Biodefense Sales Share by Players/Suppliers Figure 2017 United States Biodefense Sales Share by Players/Suppliers Figure United States Biodefense Market Major Players Product Revenue (Million USD) (2013-2018) Table United States Biodefense Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States Biodefense Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States Biodefense Revenue Share by Players/Suppliers Figure 2017 United States Biodefense Revenue Share by Players/Suppliers Table United States Market Biodefense Average Price (USD/Unit) of Key Players/Suppliers (2013-2018) Figure United States Market Biodefense Average Price (USD/Unit) of Key Players/Suppliers in 2017 Figure United States Biodefense Market Share of Top 3 Players/Suppliers Figure United States Biodefense Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Biodefense Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Biodefense Product Category Table United States Biodefense Sales (K Units) by Region (2013-2018) Table United States Biodefense Sales Share by Region (2013-2018) Figure United States Biodefense Sales Share by Region (2013-2018) Figure United States Biodefense Sales Market Share by Region in 2017 Table United States Biodefense Revenue (Million USD) and Market Share by Region (2013-2018) Table United States Biodefense Revenue Share by Region (2013-2018) Figure United States Biodefense Revenue Market Share by Region (2013-2018) Figure United States Biodefense Revenue Market Share by Region in 2017 Table United States Biodefense Price (USD/Unit) by Region (2013-2018) Table United States Biodefense Sales (K Units) by Type (2013-2018) Table United States Biodefense Sales Share by Type (2013-2018) Figure United States Biodefense Sales Share by Type (2013-2018) Figure United States Biodefense Sales Market Share by Type in 2017 Table United States Biodefense Revenue (Million USD) and Market Share by Type (2013-2018) Table United States Biodefense Revenue Share by Type (2013-2018) Figure Revenue Market Share of Biodefense by Type (2013-2018) Figure Revenue Market Share of Biodefense by Type in 2017 Table United States Biodefense Price (USD/Unit) by Types (2013-2018) Figure United States Biodefense Sales Growth Rate by Type (2013-2018) Table United States Biodefense Sales (K Units) by Application (2013-2018) Table United States Biodefense Sales Market Share by Application (2013-2018) Figure United States Biodefense Sales Market Share by Application (2013-2018) Figure United States Biodefense Sales Market Share by Application in 2017 Table United States Biodefense Sales Growth Rate by Application (2013-2018) Figure United States Biodefense Sales Growth Rate by Application (2013-2018) Table Emergent Biosolutions Basic Information List Table Emergent Biosolutions Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Emergent Biosolutions Biodefense Sales Growth Rate (2013-2018) Figure Emergent Biosolutions Biodefense Sales Market Share in United States (2013-2018) Figure Emergent Biosolutions Biodefense Revenue Market Share in United States (2013-2018) Table Hytest Basic Information List Table Hytest Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Hytest Biodefense Sales Growth Rate (2013-2018) Figure Hytest Biodefense Sales Market Share in United States (2013-2018) Figure Hytest Biodefense Revenue Market Share in United States (2013-2018) Table GSK Basic Information List Table GSK Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure GSK Biodefense Sales Growth Rate (2013-2018) Figure GSK Biodefense Sales Market Share in United States (2013-2018) Figure GSK Biodefense Revenue Market Share in United States (2013-2018) Table Sanofi Basic Information List Table Sanofi Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Sanofi Biodefense Sales Growth Rate (2013-2018) Figure Sanofi Biodefense Sales Market Share in United States (2013-2018) Figure Sanofi Biodefense Revenue Market Share in United States (2013-2018) Table PharmAthene Basic Information List Table PharmAthene Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure PharmAthene Biodefense Sales Growth Rate (2013-2018) Figure PharmAthene Biodefense Sales Market Share in United States (2013-2018) Figure PharmAthene Biodefense Revenue Market Share in United States (2013-2018) Table Bavarian Nordic Basic Information List Table Bavarian Nordic Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Bavarian Nordic Biodefense Sales Growth Rate (2013-2018) Figure Bavarian Nordic Biodefense Sales Market Share in United States (2013-2018) Figure Bavarian Nordic Biodefense Revenue Market Share in United States (2013-2018) Table SIGA Technologies Basic Information List Table SIGA Technologies Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure SIGA Technologies Biodefense Sales Growth Rate (2013-2018) Figure SIGA Technologies Biodefense Sales Market Share in United States (2013-2018) Figure SIGA Technologies Biodefense Revenue Market Share in United States (2013-2018) Table Arbutus Biopharma Basic Information List Table Arbutus Biopharma Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Arbutus Biopharma Biodefense Sales Growth Rate (2013-2018) Figure Arbutus Biopharma Biodefense Sales Market Share in United States (2013-2018) Figure Arbutus Biopharma Biodefense Revenue Market Share in United States (2013-2018) Table DynPort Vaccine Basic Information List Table DynPort Vaccine Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure DynPort Vaccine Biodefense Sales Growth Rate (2013-2018) Figure DynPort Vaccine Biodefense Sales Market Share in United States (2013-2018) Figure DynPort Vaccine Biodefense Revenue Market Share in United States (2013-2018) Table Xoma Corporation Basic Information List Table Xoma Corporation Biodefense Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Xoma Corporation Biodefense Sales Growth Rate (2013-2018) Figure Xoma Corporation Biodefense Sales Market Share in United States (2013-2018) Figure Xoma Corporation Biodefense Revenue Market Share in United States (2013-2018) Table Ichor Medical Systems Basic Information List Table Aeolus Pharmaceuticals Basic Information List Table Achaogen Basic Information List Table Elusys Therapeutics Basic Information List Table Dynavax Technologies Basic Information List Table Cleveland BioLabs Basic Information List Table Soligenix Basic Information List Table Alnylam Pharmaceuticals Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Biodefense Figure Manufacturing Process Analysis of Biodefense Figure Biodefense Industrial Chain Analysis Table Raw Materials Sources of Biodefense Major Players/Suppliers in 2017 Table Major Buyers of Biodefense Table Distributors/Traders List Figure United States Biodefense Sales Volume (K Units) and Growth Rate Forecast (2018-2025) Figure United States Biodefense Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure United States Biodefense Price (USD/Unit) Trend Forecast (2018-2025) Table United States Biodefense Sales Volume (K Units) Forecast by Type (2018-2025) Figure United States Biodefense Sales Volume (K Units) Forecast by Type (2018-2025) Figure United States Biodefense Sales Volume (K Units) Forecast by Type in 2025 Table United States Biodefense Sales Volume (K Units) Forecast by Application (2018-2025) Figure United States Biodefense Sales Volume (K Units) Forecast by Application (2018-2025) Figure United States Biodefense Sales Volume (K Units) Forecast by Application in 2025 Table United States Biodefense Sales Volume (K Units) Forecast by Region (2018-2025) Table United States Biodefense Sales Volume Share Forecast by Region (2018-2025) Figure United States Biodefense Sales Volume Share Forecast by Region (2018-2025) Figure United States Biodefense Sales Volume Share Forecast by Region in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources